Equipment and QMS Software by Verification Process



The FDA and other regulatory agencies have stated that software validation can only be accomplished effectively if "risk-based". How can this be done in the "real world".

Why should you Attend:

Software has become pervasive in medical devices themselves, and in the controlling, running and monitoring of medical product processes, whether they be in the pharmaceutical, medical device, biologics or dietary supplements industries. A quick review of Internet forums will show much confusion about the subject.

Areas Covered in the Session:

  • Verification or Validation-FDA Expectations
  • The Project V&V Plan
  • An FDA-accepted Documentation "Model"
  • Product and Process/Test Facilities/Equipment Software V&V

Who Will Benefit:

  • Senior management in Drugs, Devices, Combination Products, Biologics, Dietary Supplements
  • QA / RA
  • Software development, Programming, Documentation, Testing teams
  • R&D

Speaker and Presenter Information

John E. Lincoln is a medical device and regulatory affairs consultant. He has helped companies to implement or modify their GMP systems and procedures, product risk management, U.S. FDA responses.

Relevant Government Agencies

FDA


Event Type
Webcast


This event has no exhibitor/sponsor opportunities


When
Wed, Mar 8, 2017, 10:00am - 11:30am


Cost

General admission:  $150.00


Website
Click here to visit event website


Organizer
NetZealous - Compliance4All


Contact Event Organizer


Join the event conversation:
@Compliance4all
#Compliance4all


Return to search results